Preview Mode Links will not work in preview mode

Evidence Based Medicine presented by InpharmD™

Sep 28, 2021

A randomized, double-blind, parallel-group, placebo-controlled, event-driven trial conducted to evaluate the effects of SGLT2 inhibition with empagliflozin on major heart failure outcomes in patients with heart failure and a preserved ejection fraction.

Sep 17, 2021

This week, InpharmD looks at two case reports discussing presentations of patients who developed Functional Neurological Disorder (FND) after receiving COVID-19 vaccination. 

Sep 9, 2021

This week, we look at two different case reports:

1) Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination

2) Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination

Tune in to learn more! 


Sep 3, 2021

A cohort study conducted to determine whether there is a dose–response relationship between the intensity of exposure to the World Trade Center (WTC) site and the risk of hepatic steatosis (HS) in the WTC General Responder Cohort (GRC).